OpenVSafe by OpenVAERS
Search V-safe

6XQ-47147-69866

4 vaccinations 10 coded responses 50 check-ins 9 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
920 / CA
Registered
2021-02-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-03
    Registered in v-safe
  2. 2021-02-03
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-03
    Survey response — day 0, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: A little light headedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  5. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-07
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Rash on both arms appeared late yesterday
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Subsiding fore arm rash on both arms
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: Rash on fore arms continues ro improve
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-10
    Survey response — day 7, dose 1
    MedDRA: Rash — Feeling: Good
    Free text: Rash on fore arms is completely resolved today
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-17
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-24
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-24
    Survey response — day 0, dose 2
    MedDRA: Dizziness, Heart rate increased — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Higher than normal pulse and dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-02-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue, Headache, Pain — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Headache, body aches, and fatigue are improving over yesterday
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  16. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · None
    Adult check-in
  17. 2021-03-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · None
    Adult check-in
  18. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-03
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-10
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-31
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-07
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-26
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-25
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-04
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-04
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  29. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  31. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  32. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-11
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-01
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-15
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-01-03
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-04-06
    Survey response — 6 months, dose 3
    MedDRA: Exposure to SARS-CoV-2, Headache, Malaise, Pain, Sinus congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Head and body aches, sinus congestion, general malaise. Found out later that several other people I was with had similar symptoms and tested positive for Covid 19
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-04
    Survey response — 12 months, dose 3
    MedDRA: Functional endoscopic sinus surgery, Office visit, Pre-existing disease, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Chronic sinus infection requiring FESS. Nasal infection still persistent. Working with infectious disease specialist. · Healthcare visit (other): Office visit
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-10-04
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  45. 2022-10-05
  46. 2022-10-10
    Dose 4 — Pfizer-BioNTech
  47. 2022-10-14
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Redness, Swelling · Headache, Abdominal pain
    Adult check-in
  48. 2022-10-15
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  49. 2022-10-16
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  50. 2022-10-17
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  51. 2022-10-24
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-10-31
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-11-07
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-11-14
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-11-21
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  56. 2023-01-09
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  57. 2023-04-10
    Survey response — 6 months, dose 4
    MedDRA: Office visit, Prostate cancer — Feeling: Good · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  58. 2023-04-10
    Report sent to call center — 6 months, dose 4
    Get care from a doctor or other healthcare professional
    1 call case(s)
  59. 2023-04-11
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  60. 2023-04-11
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-02-03Pfizer-BioNTech
22021-02-24Pfizer-BioNTech
32021-10-04Pfizer-BioNTech No
42022-10-10Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 3 — day 0, dose 1

2021-02-03

Systemic reaction (other): A little light headedness

Release 3 — days 1–6 daily, dose 1

2021-02-07

Systemic reaction (other): Rash on both arms appeared late yesterday

2021-02-08

Systemic reaction (other): Subsiding fore arm rash on both arms

2021-02-09

Systemic reaction (other): Rash on fore arms continues ro improve

Release 4 — day 7, dose 1

2021-02-10

Systemic reaction (other): Rash on fore arms is completely resolved today

Release 4 — day 0, dose 2

2021-02-24

Systemic reaction (other): Higher than normal pulse and dizziness

Release 4 — days 1–6 daily, dose 2

2021-02-26

Systemic reaction (other): Headache, body aches, and fatigue are improving over yesterday

Release 11 — 6 months, dose 3

2022-04-06

Symptoms: Head and body aches, sinus congestion, general malaise. Found out later that several other people I was with had similar symptoms and tested positive for Covid 19

Release 12 — 12 months, dose 3

2022-10-04

Symptoms: Chronic sinus infection requiring FESS. Nasal infection still persistent. Working with infectious disease specialist.
Healthcare visit (other): Office visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDFunctional endoscopic sinus surgery · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDOffice visit · · ✓
SDPain · · ✓
SDPre-existing disease · · ✓
SDProstate cancer · · ✓
SDSinus congestion · · ✓
SDSinusitis · · ✓
SRODizziness ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SROPain ✓ ✓ ✓
SRORash ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release